share_log

奥赛康:2023年度独立董事述职报告(刘剑文)

Beijing Aosaikang Pharmaceutical: 2023 Independent Director Debriefing Report (Liu Jianwen)

SZSI ·  Apr 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more